The absolute neutrophil count (ANC) >= /mm^ without colony stimulating factor support
Adequate hematologic status as demonstrated by not requiring transfusion support or granulocyte-colony stimulating factor (G-CSF) to maintain: Absolute neutrophil count (ANC) ? cells/mm, Platelet count ? x /L, Hemoglobin (Hgb) ? g/dL
Absolute neutrophil count >= /mm^ without colony stimulating factor support, within  days before the first dose of cabozantinib
The absolute neutrophil count (ANC) >= /mm^ without colony stimulating factor support within  days before the first dose of cabozantinib
Absolute neutrophil count (ANC) greater than or equal to ,/mcl, within  days prior to registration; this ANC cannot have been induced by granulocyte colony stimulating factors
Absolute neutrophil count >= /uL without growth factor support (e.g. granulocyte colony stimulating factor [GCSF]) in the previous  days
Obtained within  days prior to the first dose of cabozantinib: absolute neutrophil count (ANC) >= /mm^ without colony stimulating factor support.
Within  days prior to registration: Absolute neutrophil count (ANC) >= ,/mcl; this ANC cannot have been induced by granulocyte colony stimulating factor
Within  days before the first dose of study treatment: The absolute neutrophil count (ANC) >= /mm^ without colony stimulating factor support
Absolute neutrophil count (ANC) <  cells/uL (granulocyte colony-stimulating factor support should not be used within  weeks prior to cycle , day )
Adequate hematologic status as demonstrated by not requiring transfusion support or granulocyte-colony stimulating factor (G-CSF) to maintain: Absolute neutrophil count (ANC) ? cells/mm, Platelet count ? x /L, Hemoglobin ? g/dL; subjects with thalassemia having a hemoglobin < g/dL may be enrolled, per Investigator discretion
Absolute neutrophil count (ANC) >= ,/mcl; this ANC cannot have been induced or supported by granulocyte colony stimulating factors
Absolute neutrophil count >= ,/mcL (without granulocyte colony-stimulating factor support within  weeks prior to cycle , day )
Within  days prior to the first dose of cabozantinib: Absolute neutrophil count (ANC) >= /mm^ without colony stimulating factor support
Absolute neutrophil count (ANC) >= ,/mm^ (no colony stimulating factor [CSF] support)
Absolute neutrophil count (ANC) >= /mm^ without colony stimulating factor support
RENAL COHORT: Laboratory values as follows within  days before the first dose of daratumumab: The absolute neutrophil count (ANC) ? /mm^ without colony stimulating factor support
BLADDER: Clinical laboratory values at screening: ANC ? /mm^ without colony stimulating factor support
Within  days before the first dose of cabozantinib: The absolute neutrophil count (ANC) >= /mm^ without colony stimulating factor support
Absolute neutrophil count (ANC) >= /mm^, without colony stimulating factor support
Absolute neutrophil count (ANC) greater than or equal to ,/mm^, equivalent to CTEP Common Terminology Criteria for Adverse Events (CTCAE) version ., grade ; this ANC cannot have been induced or supported by granulocyte colony stimulating factors
Absolute neutrophil count >= ,/ul without colony stimulating factor support
Absolute neutrophil count >/mL (without a colony stimulating factor within the last  weeks)
Absolute neutrophil count (ANC) >= . x ^/L without granulocyte colony-stimulating factor support, obtained within  days prior to initiation of study treatment
Absolute neutrophil count (ANC) >= /mm^ without colony stimulating factor support
Absolute neutrophil count (ANC) greater than or equal to ,/ul, equivalent to Common Toxicity Criteria for Adverse Events v. (CTCAE)  grade ; this ANC cannot have been induced or supported by granulocyte colony stimulating factors
Absolute neutrophil count (ANC) >= /mm^, with or without granulocyte colony-stimulating factor (G-CSF) support; this requirement may be waived if the patient has hematologic relapse of disease or if patient has not yet recovered counts from chemotherapy
Platelet count >/=, /mm, hemoglobin >/= g/dL, absolute neutrophil count >/= /mm without transfusions or granulocyte colony stimulating factor and other hematopoietic growth factors
Absolute neutrophil count (ANC) >= /mm^ without colony stimulating factor support
Bone marrow function: Absolute neutrophil count (ANC) ?  Cells/?L (with no evidence that this ANC was induced or supported by granulocyte colony stimulating factors)
Absolute neutrophil count (ANC) >=  cells/uL (without granulocyte colony-stimulating factor support within  weeks prior to cycle , day )
Absolute neutrophil count (ANC) >= /mm^ without colony stimulating factor support
Absolute neutrophil count (ANC) greater than or equal to /ul, equivalent to Common Toxicity Criteria for Adverse Events v. (CTCAE) grade ; this ANC cannot have been induced or supported by granulocyte colony stimulating factors
Absolute neutrophil count (ANC) ? ,/?L without colony-stimulating factor support
Adequate hematologic status as demonstrated by not requiring transfusion support or granulocyte-colony stimulating factor (G-CSF) to maintain: ANC ? cells/mm, Platelet count ? x /L, Hemoglobin ? g/dL
